03681 中國抗體－Ｂ
按盘价 
1.130 +0.060 (+5.607%) 盈利能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 资产回报率 (%) | -26.195% | -27.723% | -26.547% | -10.159% | -40.245% |
| 股东资金回报率 (%) | -60.388% | -47.766% | -34.571% | -11.572% | -47.663% |
| 资本运用回报率 (%) | -36.009% | -34.613% | -30.552% | -11.450% | -23.464% |
边际利润分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 毛利率 (%) | 30.916% | N/A | -- | N/A | N/A |
| 未计利息、税项、折旧及摊销前利润率 (%) | -15138.388% | N/A | -1058.002% | N/A | N/A |
| 税前边际利润率 (%) | -17810.330% | N/A | -1112.160% | N/A | N/A |
| 纯利率 (%) | -17810.330% | N/A | -1112.160% | N/A | N/A |
变现能力分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 流动比率 (X) | 1.565 X | 2.386 X | 6.056 X | 15.889 X | 11.390 X |
| 速动比率 (X) | 1.565 X | 2.386 X | 6.056 X | 15.889 X | 11.390 X |
财务杠杆分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 总负债 / 总资产比率 (%) | 65.135% | 49.464% | 34.698% | 12.617% | 11.856% |
| 总债项 / 总资产比率 (%) | 53.175% | 35.423% | 26.444% | 8.662% | 4.175% |
| 净债项 / 总资产比率 (%) | 29.152% | 1.138% | -27.603% | -63.083% | -89.339% |
| 总债项 / 股东资金比率 (%) | 152.515% | 70.094% | 40.495% | 9.913% | 4.737% |
| 长期债项 / 股东资金比率 (%) | 128.410% | 61.106% | 38.673% | 8.481% | 4.026% |
| 净债项 / 股东资金比率 (%) | 83.612% | 2.251% | -42.269% | -72.191% | -101.355% |
| 净现金 / (债项) ($) | (2.47亿) | (1.15千万) | 2.88亿 | 7.13亿 | 11.47亿 |
| 每股净现金 / (债项) ($) | (0.239) | (0.011) | 0.286 | 0.708 | 1.140 |
| 总债项 / 资本运用比率 (%) | 66.773% | 43.508% | 29.202% | 9.138% | 4.553% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
营运效率分析
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| 存货周转率日数 (日) | N/A | N/A | N/A | N/A | -- |
| 应收贸易帐周转率日数 (日) | N/A | N/A | N/A | N/A | N/A |
| 应付贸易帐周转率日数 (日) | N/A | N/A | N/A | N/A | N/A |
| 备注： | 实时报价更新时间为14/11/2024 18:00 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -90,622,000 |
| 增长率 | -32.420% |
| 每股盈利/(亏损) | RMB -0.080 |
| 每股账面资产净值 (¥) | RMB 0.254 |